Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States.

Liberman, Joshua N; Pesa, Jacqueline; Petrillo, Mary Pat; Ruetsch, Charles.

BMC Psychiatry ; 22(1): 376, 2022 06 02.

Artigo em Inglês | MEDLINE | ID: mdl-35655167

2.

Adherence to augmentation therapy for the treatment of major depressive disorder.

Forma, Felicia; Liberman, Joshua N; Rui, Pinyao; Ruetsch, Charles.

Expert Rev Pharmacoecon Outcomes Res ; 23(3): 327-335, 2023 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-36697398

3.

Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.

Tkacz, Joseph; Severt, Jamie; Cacciola, John; Ruetsch, Charles.

Am J Addict ; 21(1): 55-62, 2012.

Artigo em Inglês | MEDLINE | ID: mdl-22211347

4.

Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder.

Forma, Felicia; Liberman, Joshua N; Rui, Pinyao; Wiggins, Emily; Ruetsch, Charles.

Neuropsychiatr Dis Treat ; 18: 2467-2475, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-36330373

5.

Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.

Shah, Neel; Velez, Fulton F; Colman, Samuel; Kauffman, Laura; Ruetsch, Charles; Anastassopoulos, Kathryn; Maricich, Yuri.

Adv Ther ; 39(9): 4146-4156, 2022 09.

Artigo em Inglês | MEDLINE | ID: mdl-35819569

6.

Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder.

Liberman, Joshua N; Bhattacharjee, Sandipan; Rui, Pinyao; Ruetsch, Charles; Rothman, Brian; Kulkarni, Amit; Forma, Felicia.

Health Serv Res Manag Epidemiol ; 9: 23333928221111864, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-35832488

7.

Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.

Velez, Fulton F; Anastassopoulos, Kathryn P; Colman, Samuel; Shah, Neel; Kauffman, Laura; Murphy, Sean M; Ruetsch, Charles; Maricich, Yuri A.

Adv Ther ; 39(9): 4131-4145, 2022 09.

Artigo em Inglês | MEDLINE | ID: mdl-35799080

8.

Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence.

Liberman, Joshua N; Davis, Tigwa; Velligan, Dawn; Robinson, Delbert; Carpenter, William; Jaeger, Chris; Waters, Heidi; Ruetsch, Charles; Forma, Felicia.

Psychiatr Res Clin Pract ; 4(2): 61-70, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-36254189

9.

The Association between Patient Activation and Outcomes among Severely Mentally Ill Patients.

Forma, Felicia; Clerie, Jennifer; Davis, Tigwa; Clovie, Kelly; Ruetsch, Charles.

J Behav Health Serv Res ; 48(3): 382-399, 2021 07.

Artigo em Inglês | MEDLINE | ID: mdl-33205314

10.

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic.

Velez, Fulton F; Colman, Sam; Kauffman, Laura; Ruetsch, Charles; Anastassopoulos, Kathryn.

Expert Rev Pharmacoecon Outcomes Res ; 21(1): 69-76, 2021 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-33146558

11.

Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.

Velez, Fulton F; Colman, Sam; Kauffman, Laura; Ruetsch, Charles; Anastassopoulos, Kathryn; Maricich, Yuri A.

Clinicoecon Outcomes Res ; 13: 909-916, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-34754205

12.

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms.

Ruetsch, Charles; Davis, Tigwa; Liberman, Joshua N; Velligan, Dawn I; Robinson, Delbert; Jaeger, Chris; Carpenter, William; Forma, Felica.

Neuropsychiatr Dis Treat ; 17: 3715-3726, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-34938079

13.

Empirical view of opioid dependence.

Ruetsch, Charles.

J Manag Care Pharm ; 16(1 Suppl B): S9-13, 2010 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-20146549

14.

Practice strategies to improve compliance and patient self-management.

Ruetsch, Charles.

J Manag Care Pharm ; 16(1 Suppl B): S26-7, 2010 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-20146552

15.

Opioid dependence treatment and guidelines.

Nicholls, Lance; Bragaw, Lisa; Ruetsch, Charles.

J Manag Care Pharm ; 16(1 Suppl B): S14-21, 2010 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-20146550

16.

Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care.

Liberman, Joshua N; Davis, Tigwa; Pesa, Jacqui; Chow, Wing; Verbanac, John; Heverly-Fitt, Sara; Ruetsch, Charles.

J Manag Care Spec Pharm ; 26(8): 987-995, 2020 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-32715964

17.

Treating prescription opioid dependence.

Ruetsch, Charles.

JAMA ; 312(11): 1145-6, 2014 Sep 17.

Artigo em Inglês | MEDLINE | ID: mdl-25226480

18.

Association between meaningful use of electronic health records and patient health outcomes in schizophrenia: a retrospective database analysis.

Ng-Mak, Daisy; Ruetsch, Charles.

Am J Manag Care ; 25(9 Suppl): S159-S165, 2019 07.

Artigo em Inglês | MEDLINE | ID: mdl-31318518

19.

A claims-based algorithm to reduce relapse and cost in schizophrenia.

Waters, Heidi C; Ruetsch, Charles; Tkacz, Joseph.

Am J Manag Care ; 25(12): e373-e378, 2019 12 01.

Artigo em Inglês | MEDLINE | ID: mdl-31860231

20.

Claims-based proxies of patient instability among commercially insured adults with schizophrenia.

Ruetsch, Charles; Un, Hyong; Waters, Heidi C.

Clinicoecon Outcomes Res ; 10: 259-267, 2018.

Artigo em Inglês | MEDLINE | ID: mdl-29765242

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States.

Adherence to augmentation therapy for the treatment of major depressive disorder.

Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.

Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder.

Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.

Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder.

Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.

Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence.

The Association between Patient Activation and Outcomes among Severely Mentally Ill Patients.

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic.

Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms.

Empirical view of opioid dependence.

Practice strategies to improve compliance and patient self-management.

Opioid dependence treatment and guidelines.

Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care.

Treating prescription opioid dependence.

Association between meaningful use of electronic health records and patient health outcomes in schizophrenia: a retrospective database analysis.

A claims-based algorithm to reduce relapse and cost in schizophrenia.

Claims-based proxies of patient instability among commercially insured adults with schizophrenia.